CAPR vs CFLT · $1.62B cap vs rev $963.6M
Capricor Therapeutics Inc (CAPR) versus Confluent Inc (CFLT) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CAPR currently screens at market cap $1.62B.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
CAPR currently screens at market cap $1.62B. CFLT currently screens at market cap $11.13B.
Not investment advice. Open the CAPR and CFLT stock pages for the full models.
Not investment advice.